Side-by-side comparison of AI visibility scores, market position, and capabilities
FY2025 (ended Mar 31, 2025): JPY 21.6887T (+6.2%) | Operating Profit: JPY 1.2134T (-12.2%) | FY2024: JPY 20.4286T (+20.8%) | Q3 FY2024 (9 months): Op Profit JPY 1.1399T, margin 7.0% | Auto sales down 297k (Asia impact) | FY2026 guidance: Net profit JPY 250B (-70.1%), Revenue JPY 20.3T (-6.4%)
Honda Motor Co., Ltd. is a Japanese multinational mobility conglomerate founded in 1948 by Soichiro Honda and Takeo Fujisawa in Hamamatsu, Japan. Starting as a motorcycle manufacturer, Honda expanded into automobiles, power equipment, marine engines, and aerospace, becoming one of the largest and most diversified mobility companies in the world. With over 90 million vehicles sold globally and a reputation built on engineering reliability, fuel efficiency, and innovation, Honda operates manufacturing facilities across more than 30 countries on six continents.\n\nHonda's automotive lineup ranges from mass-market sedans and SUVs — including the best-selling Civic and CR-V — to trucks, minivans, and the premium Acura brand. The company is executing a major pivot to electrification through the Honda 0 Series, a new EV architecture designed from the ground up for battery-electric vehicles launching in 2026. Honda's partnership with General Motors on battery technology, combined with its investment in solid-state battery development, reflects a multi-path electrification strategy designed to hedge technology risk while building scale.\n\nHonda reported FY2025 revenue of JPY 21.7 trillion, a 6.2% year-over-year increase, driven by strong North American demand and favorable currency tailwinds. The company faces intensifying competition from Chinese EV manufacturers in Asia and is exploring a potential merger with Nissan as part of broader Japanese automotive consolidation. Honda's engineering culture, global manufacturing scale, and brand credibility in reliability position it as a resilient and well-capitalized incumbent navigating the EV transition.
Viz.ai applies AI to medical imaging to detect critical conditions and automatically coordinate care teams, reducing time from diagnosis to treatment for stroke and other emergencies.
Viz.ai is a healthcare AI company founded in 2016 that applies computer vision and AI to medical imaging to detect critical conditions and automate care coordination workflows. The platform analyzes CT scans and other medical images in real time, identifying conditions including large vessel occlusion stroke, pulmonary embolism, aortic dissection, and incidental findings, then automatically notifying and coordinating the relevant specialists through a HIPAA-compliant communication platform. Viz.ai has received FDA clearance for over 20 AI algorithms and is deployed at over 1,400 hospital sites across the United States. The company raised over $250M at a $1.2B valuation and has demonstrated that AI-powered care coordination reduces door-to-treatment time for stroke by tens of minutes, which translates directly into better patient outcomes. The platform creates a connected care team workflow where radiologists, neurologists, ER physicians, and interventionalists are automatically looped in when a critical finding is detected. Viz.ai serves as essential care coordination infrastructure for time-sensitive conditions where rapid multi-specialty response is critical to preventing death or disability.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.